Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CAPN1 | P07384 | 15/20 | 0.71 |
| ▸ | CAPNS1 | P04632 | 3/20 | 0.65 |
| ▸ | CTSK | P43235 | 3/20 | 0.58 |
| ▸ | CASP1 | P29466 | 1/20 | 0.54 |
| ▸ | CASP3 | P42574 | 1/20 | 0.54 |
| ▸ | CTSL | P07711 | 2/20 | 0.53 |
| ▸ | CTSB | P07858 | 1/20 | 0.53 |
| ▸ | CTSS | P25774 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8809563 | 1.00 | CAPN1 (0.71) | CAPN1CAPNS1CTSKCASP1CASP3 | |
| SCHEMBL8408034 | 0.90 | CAPN1 (0.71) | CAPN1CAPNS1CTSKCASP1CASP3 | |
| SCHEMBL8408028 | 0.90 | CAPN1 (0.71) | CAPN1CAPNS1CTSKCASP1CASP3 | |
| SCHEMBL8810532 | 0.89 | CAPN1 (0.72) | CAPN1CAPNS1CASP1CASP3CTSL | |
| SCHEMBL8810545 | 0.89 | CAPN1 (0.72) | CAPN1CAPNS1CASP1CASP3CTSL | |
| SCHEMBL8404253 | 0.89 | CAPN1 (0.62) | CAPN1CAPNS1CTSKCASP1CASP3 | |
| SCHEMBL8404257 | 0.89 | CAPN1 (0.62) | CAPN1CAPNS1CTSKCASP1CASP3 | |
| SCHEMBL8810040 | 0.89 | CAPN1 (0.70) | CAPN1CAPNS1CTSKCASP1CASP3 | |
| SCHEMBL8810031 | 0.89 | CAPN1 (0.70) | CAPN1CAPNS1CTSKCASP1CASP3 | |
| SCHEMBL8807784 | 0.88 | CAPN1 (0.61) | CAPN1CAPNS1CTSKCASP1CASP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0810221-A1 | OXYGEN-CONTAINING HETEROCYCLIC DERIVATIVES | MITSUBISHI CHEMICAL CORPORATION (JP) | 1997-12-03 | — | — | EP | disclosed |